Big-name drugmakers want to profit from selling lower-priced copies of rivals' expensive biotechnology drugs. Patients and doctors want to pay less for medicine.
What's Harder Than Making Copycat Biotech Drugs? Selling Them
Comment
Show comments
Hide Comments
